Comparison of Busulfan and Cyclophosphamide (Bu-Cy)-Based Standard Myeloablative Conditioning (MAC) Vs. Fludarabine and Busulfan (Flu-Bu)-Based Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) Patients in First Complete Remission (CR1) Aged >40 Years: a Retrospective Analysis From the Acute Leukemia Working Party of EBMT

被引：5
|
作者：
Mohty, Mohamad [1 ]
Labopin, Myriam [2 ,3 ]
Socie, Gerard [4 ]
Milpied, Noel-Jean [5 ]
Attal, Michel [6 ]
Blaise, Didier [7 ]
Ringden, Olle [8 ]
Brown, Paul [9 ]
Lorentz, Brinch [10 ]
Brune, Mats L. [11 ]
Hamladji, Rose-Marie [12 ]
Duarte, Rafael F. [13 ]
Nagler, Arnon [14 ]
Rocha, Vanderson [15 ,16 ]
机构：
[1] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[2] Hop St Antoine, F-75571 Paris, France
[3] Univ Paris 06, EBMT ALWP Off, F-75571 Paris, France
[4] Serv Greffe Moelle, Paris, France
[5] CHU Bordeaux, Bordeaux, France
[6] Univ Hosp, CHU Dept Hematol, Toulouse, France
[7] Inst J Paoli I Calmettes, F-13009 Marseille, France
[8] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden
[9] St James Hosp, Trinity Coll, Dublin 8, Ireland
[10] Univ Oslo, Rikshosp, N-0027 Oslo, Norway
[11] Sahlgrens Univ Hosp, Ctr Hematopoiet Cell Transplantat, Gothenburg, Sweden
[12] Pierre & Marie Curie Ctr, Serv Hematol Greffe de Moelle, Algiers, Algeria
[13] Inst Catalan Oncol, Barcelona, Spain
[14] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel
[15] Hop St Louis, APHP, BMT Unit, EBMT ALWP, Paris, France
[16] Univ Paris 07, Paris, France
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.4030.4030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1306 / 1306
页数：1
相关论文
共 23 条
  • [1] Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1): a Retrospective Analysis of 1200 Patients From the Acute Leukemia Working Party of EBMT.
    Mohty, Mohamad
    Labopin, Myriam
    Janssen, Jeroen J. W. M.
    Mufti, Ghulam J.
    Cornelissen, J. J.
    Milpied, Noel-Jean
    Sengeloev, Henrik
    Blaise, Didier
    Petersen, Eefke
    Goker, Hakan
    Gribben, John G.
    Nagler, Arnon
    Rocha, Vanderson
    BLOOD, 2009, 114 (22) : 489 - 489
  • [2] Allogeneic (Allo) Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1) with a Reduced Intensity Conditioning (RIC) of Fludarabine (Flu), 2 Day Busulfan (Bu2) and Horse ATG (hATG): The UMass Experience
    Nath, Rajneesh
    Cerny, Jan
    Ramanathan, Muthalagu
    Raffel, Glen
    George, Mridula
    Al-Mansour, Zeina
    Petrillo-Deluca, Laura
    Martin, Tzafra
    Desai, Zankar
    Bednarik, Jayde
    Kroll-Desrosiers, Aimee
    Rosmarin, Alan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S156 - S157
  • [3] REDUCED INTENSITY VS CONVENTIONAL MYELOABLATIVE CONDITIONING (RIC VS. MAC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A SURVEY FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
    Mohty, M.
    Labopin, M.
    Ruutu, T.
    De Lavallade, H.
    Gratwohl, A.
    Socie, G.
    Esteve, J.
    Tabrizi, R.
    Nagler, A.
    Rocha, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 2 - 2
  • [4] Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT
    Mohty, Mohamad
    Labopin, Myriam
    Finke, Jurgen
    Schmid, Christoph
    Kolb, H. J.
    Bacigalupo, Andrea
    Blaise, Didier
    Cornillon, Jerome
    Milpied, Noel
    Cabrera-Marin, J. R.
    Ciceri, Fabio
    Rocha, Vanderson
    Nagler, Arnon
    BLOOD, 2010, 116 (21) : 1414 - 1414
  • [5] Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
    Mohty, Mohamad
    Labopin, Myriam
    Milpied, Noel-Jean
    Cornelissen, Jan J.
    Blaise, Didier
    Petersen, Eefke
    Theorin, Niklas
    Goker, Hakan
    Socie, Gerard
    Rocha, Vanderson
    BLOOD, 2008, 112 (11) : 134 - 135
  • [6] Reduced Intensity Versus Conventional Myeloablative Conditioning (RIC vs. MAC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Lymphoblastic Leukemia (ALL): A Survey from the Acute Leukemia Working Party of EBMT
    Mohty, Mohamad
    Labopin, Myriam
    Ruutu, Tapani
    Gratwohl, Alois
    Socie, Gerard
    Esteve, Jordi
    Tabrizi, Reza
    Nagler, Arnon
    Rocha, Vanderson
    BLOOD, 2008, 112 (11) : 294 - 295
  • [7] Reduced intensity conditioning (RIC) prior to allogeneic stem cell transplantation (SCT) for patients (PTS) with acute myeloid leukemia (AML) in first complete remission (CR1)
    Vey, N.
    Boiron, J. M.
    Faucher, C.
    Mohty, M.
    Bay, J. O.
    Bardoux, V. J.
    Perreau, V
    Coso, D.
    Pigneux, A.
    Blaise, D.
    ANNALS OF HEMATOLOGY, 2006, 85 : 27 - 27
  • [8] Intravenous Busulfan (IV Bu)-Based Conditioning Regimen Before Allogeneic Stem Cell Transplantation (allo-SCT) for Adults with Acute Lymphoid Leukemia (ALL): A Aurvey From the Acute Leukemia Working Party of EBMT
    Mohty, Mohamad
    Labopin, Myriam
    Sanz, Miguel A.
    Hamljadi, Rose-Marie
    Koza, Vladimir
    Arcese, William
    Campos, Antonio
    Milpied, Noel-Jean
    Nagler, Arnon
    BLOOD, 2011, 118 (21) : 1294 - 1294
  • [9] Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT.
    Yeshurun, Moshe
    Labopin, Myriam
    Blaise, Didier
    Cornelissen, Jan
    Sengeloev, Henrik
    Vindelov, Lars
    Kuball, Jurgen H.
    Chevallier, Patrice
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [10] IMPACT OF CYTOGENETICS RISK ON OUTCOME AFTER REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FROM AN HLA IDENTICAL SIBLING FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CRI)
    Mobty, M.
    Labopin, M.
    Milpied, N.
    Cornelissen, J. J.
    Blaise, D.
    Petersen, E.
    Theorin, N.
    Goker, H.
    Socie, G.
    Rocha, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 21 - 21
123